• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗不良事件富集检验。

Vaccine adverse event enrichment tests.

机构信息

Department of Statistics, University of Michigan, Ann Arbor, Michigan, USA.

Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Stat Med. 2021 Aug 30;40(19):4269-4278. doi: 10.1002/sim.9027. Epub 2021 May 9.

DOI:10.1002/sim.9027
PMID:33969520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8487909/
Abstract

Vaccination safety is critical for individual and public health. Many existing methods have been used to conduct safety studies with the VAERS (Vaccine Adverse Event Reporting System) database. However, these methods frequently identify many adverse event (AE) signals and they are often hard to interpret in a biological context. The AE ontology introduces biologically meaningful structures to the Vaccine Adverse Event Reporting System (VAERS) database by connecting similar AEs, which provides meaningful interpretation for the underlying safety issues. In this paper, we develop rigorous statistical methods to identify "interesting" AE groups by performing AE enrichment analysis. We extend existing gene enrichment tests to perform AE enrichment analysis, while incorporating the special features of the AE data. The proposed methods were evaluated using simulation studies and were further illustrated on two studies using VAERS data. The proposed methods were implemented in R package AEenrich and can be installed from the Comprehensive R Archive Network, CRAN, and source code are available at https://github.com/umich-biostatistics/AEenrich.

摘要

疫苗接种安全对于个人和公共健康至关重要。许多现有的方法已经被用于使用 VAERS(疫苗不良事件报告系统)数据库进行安全性研究。然而,这些方法经常会识别出许多不良事件(AE)信号,并且在生物学背景下往往难以解释。AE 本体论通过连接相似的 AE,为疫苗不良事件报告系统(VAERS)数据库引入了具有生物学意义的结构,为潜在的安全问题提供了有意义的解释。在本文中,我们通过进行 AE 富集分析,开发了严格的统计方法来识别“有趣”的 AE 组。我们扩展了现有的基因富集测试来进行 AE 富集分析,同时结合了 AE 数据的特殊特征。所提出的方法通过模拟研究进行了评估,并进一步在使用 VAERS 数据的两项研究中进行了说明。所提出的方法已在 R 包 AEenrich 中实现,可从 Comprehensive R Archive Network,CRAN 安装,源代码可在 https://github.com/umich-biostatistics/AEenrich 获得。

相似文献

1
Vaccine adverse event enrichment tests.疫苗不良事件富集检验。
Stat Med. 2021 Aug 30;40(19):4269-4278. doi: 10.1002/sim.9027. Epub 2021 May 9.
2
Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system.利用本体挖掘大型频率表中的不良事件,在疫苗不良事件报告系统中的应用。
Stat Med. 2023 May 10;42(10):1512-1524. doi: 10.1002/sim.9684. Epub 2023 Feb 15.
3
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.
4
Advanced Clinical Decision Support for Vaccine Adverse Event Detection and Reporting.用于疫苗不良事件检测和报告的高级临床决策支持
Clin Infect Dis. 2015 Sep 15;61(6):864-70. doi: 10.1093/cid/civ430. Epub 2015 Jun 9.
5
Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017.九价人乳头瘤病毒疫苗在孕妇中的安全性:2014-2017 年疫苗不良事件报告系统(VAERS)中的不良事件报告。
Vaccine. 2019 Feb 21;37(9):1229-1234. doi: 10.1016/j.vaccine.2018.11.077. Epub 2019 Jan 16.
6
Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.2000年至2013年向美国疫苗不良事件报告系统(VAERS)报告的疫苗接种错误。
Vaccine. 2015 Jun 22;33(28):3171-8. doi: 10.1016/j.vaccine.2015.05.006. Epub 2015 May 14.
7
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.从疫苗不良事件报告系统中了解疫苗安全信息。
Pediatr Infect Dis J. 2004 Apr;23(4):287-94. doi: 10.1097/00006454-200404000-00002.
8
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.2009-2015 年疫苗不良事件报告系统(VAERS)中四价人乳头瘤病毒疫苗上市后安全性监测。
Vaccine. 2018 Mar 20;36(13):1781-1788. doi: 10.1016/j.vaccine.2018.02.034. Epub 2018 Feb 21.
9
Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.1990 年至 2014 年向疫苗不良事件报告系统(VAERS)报告的主要出生缺陷。
Birth Defects Res. 2017 Jul 17;109(13):1057-1062. doi: 10.1002/bdr2.23622.
10
A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data.一种基于疫苗不良事件报告系统数据的不良效应时间变化的信号检测方法。
BMC Med Inform Decis Mak. 2017 Jul 5;17(Suppl 2):76. doi: 10.1186/s12911-017-0472-y.

引用本文的文献

1
BAYESIAN LEARNING OF COVID-19 VACCINE SAFETY WHILE INCORPORATING ADVERSE EVENTS ONTOLOGY.结合不良事件本体论对新冠疫苗安全性进行贝叶斯学习
Ann Appl Stat. 2023 Dec;17(4):2887-2902. doi: 10.1214/23-aoas1743. Epub 2023 Oct 30.
2
Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system.利用本体挖掘大型频率表中的不良事件,在疫苗不良事件报告系统中的应用。
Stat Med. 2023 May 10;42(10):1512-1524. doi: 10.1002/sim.9684. Epub 2023 Feb 15.

本文引用的文献

1
Improvement in the Analysis of Vaccine Adverse Event Reporting System Database.疫苗不良事件报告系统数据库分析的改进
Stat Biopharm Res. 2020;12(3):303-310. doi: 10.1080/19466315.2020.1764862. Epub 2020 Jun 8.
2
Gene Set Analysis: Challenges, Opportunities, and Future Research.基因集分析:挑战、机遇与未来研究
Front Genet. 2020 Jun 30;11:654. doi: 10.3389/fgene.2020.00654. eCollection 2020.
3
Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.四价减毒活流感疫苗在2至49岁人群中的安全性。
Vaccine. 2017 Mar 1;35(9):1254-1258. doi: 10.1016/j.vaccine.2017.01.062. Epub 2017 Feb 2.
4
An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.一种鼻内给药的蛋白酶体佐剂三价流感疫苗在人类病毒性流感攻毒模型中是安全、免疫原性良好且有效的。血清IgG和黏膜IgA是预防感染相关疾病的重要保护相关性指标。
PLoS One. 2016 Dec 22;11(12):e0163089. doi: 10.1371/journal.pone.0163089. eCollection 2016.
5
Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases.甲型肝炎和乙型肝炎单价及联合疫苗不良事件的统计与本体分析。
Sci Rep. 2016 Oct 3;6:34318. doi: 10.1038/srep34318.
6
Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events.基于本体的药物相关性神经病变不良事件的收集、表征与分析。
J Biomed Semantics. 2016 May 21;7:29. doi: 10.1186/s13326-016-0069-x. eCollection 2016.
7
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).疫苗不良事件报告系统(VAERS)中的安全性监测。
Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22.
8
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014.2013年7月至2014年6月美国四价减毒活流感疫苗的上市后监测,疫苗不良事件报告系统(VAERS)
Vaccine. 2015 Apr 15;33(16):1987-92. doi: 10.1016/j.vaccine.2015.01.080. Epub 2015 Feb 9.
9
Continuous sequential boundaries for vaccine safety surveillance.疫苗安全性监测的连续序贯界限
Stat Med. 2014 Aug 30;33(19):3387-97. doi: 10.1002/sim.6161. Epub 2014 Apr 1.
10
The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines.疫苗不良事件本体论(OVAE)及其在表示和分析与美国许可的人用疫苗相关的不良事件中的应用。
J Biomed Semantics. 2013 Nov 26;4(1):40. doi: 10.1186/2041-1480-4-40.